Brain magnetic resonance imaging (MRI) is a key tool for diagnosing
neurodegenerative diseases such as Alzheimer’s
disease (AD). However, MRI
analysis by visual interpretation and
reading can be
time -consuming and requires specialized expertise.
Brain MRI-based
artificial intelligence (AI)
software has been developed to
aid clinicians in diagnosing and managing
neurodegenerative disorders , including AD. This study demonstrates the clinical application of the AI
software for volumetric
analysis of
brain MRI scans in
patients within the AD spectrum. In the current case series, four
patients with
memory impairment visited the
memory clinic of Yeouido St. Mary’s
Hospital . They underwent a series of assessments, including automated
analysis of AI-based
software for
brain MRI volumetric measurements. The information provided by the
software was highly accurate, consistent, and was especially valuable for the
early diagnosis and
monitoring of
disease progression . The results imply that this
technology potentially
aids in the early
detection and management of AD, making it a valuable tool for clinicians in the
diagnosis of
neurodegenerative diseases .